home / stock / inab / inab quote
Last: | $1.01 |
---|---|
Change Percent: | -0.01% |
Open: | $1.04 |
Close: | $1.01 |
High: | $1.05 |
Low: | $0.995 |
Volume: | 106,433 |
Last Trade Date Time: | 05/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.01 | $1.04 | $1.01 | $1.05 | $0.995 | 106,433 | 05-24-2024 |
$1.0399 | $1.03 | $1.0399 | $1.05 | $1.0169 | 24,335 | 05-23-2024 |
$1.05 | $1.02 | $1.05 | $1.08 | $1.01 | 70,418 | 05-22-2024 |
$1.01 | $1.021 | $1.01 | $1.03 | $0.9999 | 67,979 | 05-21-2024 |
$1.02 | $1.03 | $1.02 | $1.06 | $0.99 | 138,587 | 05-20-2024 |
$1.03 | $1.04 | $1.03 | $1.05 | $1.02 | 37,495 | 05-17-2024 |
$1.02 | $1.12 | $1.02 | $1.15 | $1 | 186,426 | 05-16-2024 |
$1.13 | $1.04 | $1.13 | $1.16 | $0.99 | 793,994 | 05-15-2024 |
$1.04 | $1.04 | $1.04 | $1.05 | $1.0058 | 112,393 | 05-14-2024 |
$1.02 | $1.03 | $1.02 | $1.03 | $0.9924 | 44,991 | 05-13-2024 |
$1.01 | $0.9926 | $1.01 | $1.0199 | $0.9837 | 107,732 | 05-10-2024 |
$1.01 | $1.01 | $1.01 | $1.03 | $0.98 | 92,980 | 05-09-2024 |
$1.01 | $1 | $1.01 | $1.03 | $1 | 49,584 | 05-08-2024 |
$1.01 | $1.02 | $1.01 | $1.03 | $1 | 65,973 | 05-07-2024 |
$0.9981 | $1.01 | $0.9981 | $1.03 | $0.9734 | 65,726 | 05-06-2024 |
$1 | $1.05 | $1 | $1.05 | $1 | 83,980 | 05-03-2024 |
$1.02 | $1.01 | $1.02 | $1.07 | $1 | 196,108 | 05-02-2024 |
$1.04 | $1.02 | $1.04 | $1.07 | $0.9785 | 72,229 | 05-01-2024 |
$1.02 | $0.9804 | $1.02 | $1.05 | $0.9804 | 48,016 | 04-30-2024 |
$0.9901 | $1.04 | $0.9901 | $1.04 | $0.9734 | 80,956 | 04-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
IN8bio Inc. Company Name:
INAB Stock Symbol:
NASDAQ Market:
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-del...
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced multiple presentations at the International Society for Cell & Gene Therapy 2024, to be held May 28 th ...
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-del...